166 T2D has long been found mostly in adults, but it is increasingly common in adolescents and children due to the increase in obesity in these individuals
Additionally, athletes should consider giving more time between their meal and their workout, since the delayed gastric emptying can cause heartburn or acid reflux
Our analysis found that patients taking tirzepatide were significantly more likely to achieve weight loss: Those taking tirzepatide were 1.8 times more likely than those taking semaglutide to achieve 5% weight loss, 2.5 times more likely than those taking semaglutide to achieve 10% weight loss, And 3.2 times more likely than those taking semaglutide to achieve 15% weight loss
Conclusion Both Semaglutide and Tirzepatide represent significant advancements in the treatment of type 2 diabetes, offering effective glycemic control and weight management benefits
The most common side effects of all five FDA-approved drugs include: Nausea Vomiting Diarrhea or constipation Stomach pain Other side effects that may occur include: Indigestion Gas/burping Bloating Tiredness Low blood sugar Decreased appetite Hair loss Injection site reactions (not applicable to Rybelsus, which is taken by mouth) Symptoms of a serious allergic reaction, such as hives, trouble breathing, or swelling of the face, lips, tongue, or throat, require emergency medical help